跳至主要内容
临床试验/NL-OMON48989
NL-OMON48989招募中不适用

A feasibility study on Cerenkov Luminescence Imaging using Gallium-68 PSMA during prostate cancer surgery - CLIPPS-Cerenkov Luminescence Imaging during Prostate cancer Surgery

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational invasive

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Primary prostate cancer >18 year, eligible for PSMA PET scan (PSA>=20 ng/mL
  • or >=cT3 or Gleason>=7)
  • - Tumour larger than 2cm on MRI.
  • - Signed informed consent
  • - Voluntary understanding
  • - Scheduled for radical prostatectomy surgery
  • - PSMA uptake on pre-operative 68Ga-PSMA PET scan

排除标准

  • - Usage of Indocyanine green (ICG) during surgery
  • - No PSMA uptake on clinical PET/CT-scan
  • - Subjects who have an existing medical condition that would compromise their
  • participation in the study

研究者

发起方
Antoni van Leeuwenhoek Ziekenhuis

相似试验